A leading pharmaceutical brand struggled with fragmented sales and inventory management across regions. Variations in packaging (6, 12, or 18 tablets per strip) created uneven demand and inconsistent stocking patterns. Doctors’ prescription trends and consumer behavior shifted frequently, making it difficult to forecast sales accurately. This led to recurring supply chain inefficiencies, high recall rates, and missed revenue opportunities.
We conducted a comprehensive transformation program combining stakeholder interviews, expert insights, and consumer feedback in a digitized framework to boost trust and transparency. Key actions included: